Skip to content

The Bowdoin Group Places Christopher Hall as CEO for Khosla Ventures-Backed DiscernDx

Posted by Lauren Kendall on March 5, 2021
Press Release Tombstone - DiscernDx CEOMarch 5, 2021 The Bowdoin Group, an award winning executive search firm with deep expertise in leadership search and strategic company build-outs for high growth companies, is pleased to announce the placement of Christopher Hall as the new Chief Executive Officer at DiscernDx, the Palo Alto-based multi-omics platform backed by Khosla Ventures.

As CEO, Hall will partner closely with the Board and executive team to help the company drive its next evolution as a high performing, industry leading, multi-omics platform. He will be focused on developing and leading the growth strategy, both organically and through acquisitions, while creating additional world-class, disease-agnostic diagnostic technology, data, and analytics products.

Hall brings over 20 years of experience in general management and product development within the diagnostics space. Most recently, Hall served as President, COO, and Chief Commercial officer at Veracyte where he led the company’s commercial entry into endocrinology, business strategy for Veracyte’s products in endocrinology and pulmonology, and took on a greater role with investor relations and corporate strategy. At Veracyte, he also led sales, marketing, laboratory, and customer service operations, as well as managed care and billing functions. Prior to Veracyte, Hall served as SVP and Chief Business Officer, at Berkeley HeartLab, Inc. (part of Celera Corporation), where he helped a new product launch and restructured operations to improve profitability and streamline delivery of services.

As the executive search partner to both Khosla Ventures and DiscernDx throughout this search, The Bowdoin Group’s Sean Walker, Partner, noted: “Chris is exceptionally passionate about improving the lives of patients, which is why DiscernDx’s mission to help people get in front of their healthcare resonated so well with him. His experience in rapidly scaling successful and disruptive businesses made him a great fit for this role. Chris is well-armed to take the helm of DiscernDx and take the organization to the next level.”

“Chris has an incredible track record in the diagnostics and healthcare space,” added Josh Gottlieb, Managing Director, Digital Health at The Bowdoin Group, who served as the executive recruiter on this search. “In addition to his commercial expertise, he is a great culture fit for the startup. Chris will be able to leverage his passion for growing and scaling businesses to make an impact within the advanced diagnostics space and work to change the world of healthcare.”

Hall holds B.A. in political science and economics from DePauw University and an MBA from Harvard Business School.

About DiscernDx

At DiscernDx, we believe in the promise of precision medicine and we are working to make that promise a reality. Our solutions will enable regular health monitoring, early disease detection, and personalized care for every individual, improving lives and transforming healthcare along the way. Our mission is to empower everyone with access to individualized clinical and molecular data to proactively manage and make informed decisions about their health. We are transforming how we see, think, and interact with our health. For more information visit

About The Bowdoin Group

The Bowdoin Group is an award-winning retained executive search firm that specializes in C-suite leadership and strategic roles, commercial team expansions, and recruitment process outsourcing for a wide range of companies, ranging from venture-backed startups and emerging growth companies building out their C-suites to larger organizations sourcing talent for rapid market expansion. With deep expertise in Life Sciences, Digital Health, Software & Technology, and FinTech, Bowdoin is uniquely situated to solve recruiting challenges and unmet talent needs more than any other search firm across the U.S. due to its cross-functional reach and domain understanding across healthcare and technology. The firm continuously ranks in the top 2% of the recruiting industry in the U.S. and Canada for client and candidate satisfaction as measured by ClearlyRated’s annual NPS survey. The Bowdoin Group is also active in supporting the local entrepreneurial ecosystem as well as several non-profit organizations, including Life Science CaresNEVCAHack.Diversity, and FinTech Sandbox. For more information, visit us at and connect with us on LinkedInTwitter, and Facebook.


Emily Leinbach
Head of Marketing
(718) 263-5239